Tudor Investment Corp’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Tudor Investment Corp's NVO Position: Q2 2026 in Review
Tudor Investment Corp reduced its Novo Nordisk (NVO) stake by 59% in Q2 2026, selling an estimated $11.1M and leaving 182,382 shares worth $8.74M. The position accounts for 0.01% of the portfolio, ranked #901.
Tudor Investment Corp first reported a position in NVO in Q4 2021 and has held it in 13 quarters since. The position peaked at $22M in Q4 2023. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Tudor Investment Corp held 182,382 shares of Novo Nordisk worth $8.74M as of Q2 2026.
- Tudor Investment Corp sold 258,235 Novo Nordisk shares in Q2 2026, an estimated $11.1M.
- Novo Nordisk made up 0.01% of Tudor Investment Corp's portfolio in Q2 2026, its #901 holding.
- Tudor Investment Corp first reported a position in Novo Nordisk in Q4 2021 and has held it in 13 quarters since.
- Tudor Investment Corp's Novo Nordisk position peaked at $22M in Q4 2023.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.